Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study-Reference-Cited by-同舟云学术

Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study

Published:2019-02 Issue: Volume:54 Page:25-30
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Pelaia Corrado,Calabrese Cecilia^ORCID,Barbuto Sarah,Busceti Maria Teresa,Preianò Mariaimmacolata^ORCID,Gallelli Luca^ORCID,Savino Rocco,Vatrella Alessandro^ORCID,Pelaia Girolamo

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry, medical,Pulmonary and Respiratory Medicine

Reference63 articles.

1. After asthma: redefining airways diseases;Pavord;Lancet,2018

2. Asthma

3. Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma;Pelaia;Mediat. Inflamm.,2015

4. Eosinophilic and non-eosinophilic asthma;Carr;Am. J. Respir. Crit. Care Med.,2018

5. Emerging molecular phenotypes of asthma;Ray;Am. J. Physiol. Lung Cell Mol. Physiol.,2015

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omalizumab as the first drug of genetically engineered biological therapy: New expectations and relevance of use in bronchial asthma;Meditsinskiy sovet = Medical Council;2024-09-02

2. Type 2 severe asthma: pathophysiology and treatment with biologics;Expert Review of Respiratory Medicine;2024-07-02

3. Clinical Response Predictive Model for Omalizumab in Moderate-to-Severe Asthma Patients;International Journal of Clinical Practice;2024-05-04

4. Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients?;Pragmatic and Observational Research;2024-03

5. Omalizumab for Chinese patients with moderate-to-severe allergic asthma in real-world clinical setting: a prospective, observational study;BMJ Open Respiratory Research;2023-09